Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02091141 |
|---|---|
| Brief Title: | My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors |
| First Submitted : | March 17, 2014 |
| First Submitted that Met QC Criteria : | March 17, 2014 |
| First Posted : | March 19, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 20, 2024 |
| Last Update Posted : | February 22, 2024 |